A galectin-3 ligand corrects the impaired function of human CD4 and CD8 tumor-infiltrating lymphocytes and favors tumor rejection in mice.
暂无分享,去创建一个
P. Courtoy | B. Weynand | M. Moser | P. van der Smissen | K. Thielemans | P. van der Bruggen | C. Lurquin | J. Squifflet | C. Schmidt | N. Demotte | J. Carrasco | G. Wieërs